Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Moderna Q4 FY 2021 Earnings Report Preview: What to Look For
Moderna Q4 FY 2021 Earnings Report Preview: What to Look For
Moderna Q4 FY 2021 Earnings Report Preview: What to Look For
Submitted by
admin
on February 23, 2022 - 10:21am
Source:
Investopedia
News Tags:
Moderna Therapeutics
earnings
vaccines
COVID-19
Headline:
Moderna Q4 FY 2021 Earnings Report Preview: What to Look For
snippet:
Analysts estimate EPS of $9.80 vs. -$0.69 in Q4 FY 2020.
Revenue is expected to continue to skyrocket on soaring demand for Moderna's COVID-19 vaccine.
Moderna's COVID-19 vaccine recently received full approval for use in individuals 18 years of age or older from the FDA.
Do Not Allow Advertisers to Use My Personal information
